tumors in children Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Seattle Children's Hospital (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadtumors in children

I am/have/hadbiotherapy

I am/have/hadsteroid therapy

I am/have/hadi131 mibg therapy

I am/have/hadcytokine release syndrome

I am/have/hadsystemic corticosteroid therapy

I am/have/hadsolid tumour

I am/have/hadrecurrent disease

I am/have/hadbiological therapy

I am/have/hadapheresis

I am/have/hadsuicide

I am/have/hadsolid tumor

I am/have/hadstem cell transplant

I am/have/hadbiologic therapy

I am/have/hadneuroblastoma

I am/have/hadantibody therapy

I am/have/hadstem cell transplantation

I am/have/hadstem cell infusion

added new label for I am/have/had

more

I am looking for

I am looking foriobenguane

I am looking forcetuximab

I am looking forsteroid therapy

I am looking fortrastuzumab

I am looking forcorticosteroids

I am looking formibg

I am looking forpediatric

I am looking formetaiodobenzylguanidine

I am looking forcorticosteroid therapy

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Dermatology
Recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid tumors to evaluate the safety, feasibility, and efficacy of administering T cell products derived from the research participant's blood that have been genetically modified to express a …

iobenguane

tumors in children

cetuximab

biotherapy

steroid therapy

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.